Lassa fever

Current Topics in Microbiology and Immunology

Volumn 262, Issue , 2002, Pages 75-109

  McCormick, J B ^a   Fisher Hoch, S P ^a  

^a UNIVERSITY OF TEXAS AT BROWNSVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; INFECTION CONTROL; LASSA FEVER; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; THROMBOCYTE FUNCTION; VIREMIA; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EID: 0036186216     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-56029-3_4     Document Type: Review

References (94)

1. Lassa fever, case imported to Germany
2. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients
3. A survey for antibodies to Lassa virus among health workers in Nigeria
4. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation
5. Possible nonspecific association between malaria and HTLV-III/LAV
6. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans
7. Non-specificity of HTLV-III reactivity in sera from rural Kenya and eastern Zaire
8. A serological survey of Lassa fever in Liberia
9. Lassa fever in Onitsha, East Central State, Nigeria in 1974
10. Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus
11. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus
12. Lassa fever. Epidemio-logical aspects of the 1970 epidemic, Jos. Nigeria
13. Management of patients with suspected viral hemorrhagic fever
14. Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies
15. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever
16. A case of Lassa fever: Experience at St Thomas's Hospital
17. Electrocardiographic abnormalities in patients with Lassa fever
18. A plasma inhibitor of platelet aggregation in patients with Lassa fever
19. Acute sensorineural deafness in Lassa fever
20. A plasma inhibitor of platelet aggregation in patients with Argentine hemorrhagic fever
21. Lassa fever encephalopathy: Clinical and laboratory findings
22. Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation
23. A case of Lassa fever: Clinical and virological findings
24. Lassa fever antibodies in hospital personnel in the Plateau State of Nigeria
25. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages
26. Stringent precautions are not advisable when caring for patients with viral haemorrhagic fevers
27. Pathophysiology and treatment of Lassa fever
28. Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques
29. Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever
30. Hematologic dysfunction in Lassa fever
31. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene
32. Review of cases of nosocomial Lassa fever in Nigeria: The high price of poor medical practice
33. Effective vaccine for lassa fever
34. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings
35. Lassa virus antibodies in hospital personnel in western Liberia
36. Endemic Lassa fever in Liberia. II. Serological and virological findings in hospital patients
37. Antibodies to Lassa and Lassa-like viruses in man and mammals in the Central African Republic
38. An arenavirus isolated from wild-caught rodents (Pramys species) in the Central African Republic
39. Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations
40. Isolated case of Lassa fever in Zaria, Northern Nigeria
41. No evidence for increased risk of Lassa fever infection in hospital staff
42. An imported case of Lassa fever with late appearance of polyserositis
43. The first imported case of Lassa fever in Japan
44. Lassa fever in the United States. Investigation of a case and new guidelines for management
45. On the mode of transmission of Bolivian hemorrhagic fever
46. Recovery of a Lassa-related arenavirus in Zimbabwe
47. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys
48. Clinical virology of Lassa fever in hospitalized patients
49. Case-control study of Mastomys natalensis and humans in Lassa virus-infected households in Sierra Leone
50. Clinical observations in 42 patients with Lassa fever
51. Generation of reassortants between African arenaviruses
52. The isolation and characteristics of reassortants between the Lassa and Mopeia arenaviruses
53. Lassa and Mopeia virus replication in humn monocytes/macrophages and in endothelial cells: Different effects on IL-8 and TNF-alpha gene expression
54. Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever
55. Spermatogene ubertragung des 'Virus Marburg'. (Erreger der 'marburger affenkrankheit)
56. Clinical, epidemiologic, and therapeutic aspects of Lassa fever
57. Epidemiology and control of Lassa fever
58. Lassa fever: Epidemiology, therapy and vaccine development
59. Arenaviruses
60. Lassa virus hepatitis: A study of fatal Lassa fever in humans
61. A prospective study of the epidemiology and ecology of Lassa fever
62. A case-control study of the clinical diagnosis and course of Lassa fever
63. Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys
64. Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia
65. A hospital epidemic of Lassa fever in Zorzor, Liberia
66. Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases
67. Pediatric Lassa fever: A review of 33 Liberian cases
68. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus
69. Simultaneous expression of the Lassa virus N and GPC genes from a single recombinant vaccinia virus
70. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy
71. Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: Virulence in guinea pigs is associated with the L RNA segment
72. Mastomys (Rodentia: Muridae) species distinguished by hemoglobin pattern differences
73. Plasma from patients with severe Lassa fever profoundly modulates f-met-leu-phe induced superoxide generation in neutrophils
74. Clinical. Virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts
75. Lassa fever virus in Senegal
76. Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease
77. Nachweis des "Marburg-Virus" beim patienten
78. Identification of lppy as a Lassa-fever-related virus
79. Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea
80. Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the lassa virus nucleoprotein
81. Viral hemorrhagic fever antibodies in Nigerian populations
82. Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection
83. An outbreak of Lassa fever on the Jos plateau, Nigeria, in January-February 1970. A preliminary report
84. Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus
85. Lassa fever in children in Sierra Leone, West Africa
86. Lassa fever. A study of 23 hospital cases
87. The pathology of human Lassa fever
88. Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expression
89. Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus
90. Recent isolations of Lassa virus from Nigerian rodents
91. Isolation of an arenavirus closely related to Lassa virus from Mastomys natalensis in south-east Africa
92. Endemic Lassa fever in Liberia. VI. Village serological surveys for evidence of Lassa virus activity in Lofa County, Liberia
93. Identification of the ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury